Rationale: Hospitalization may be a valuable chance for the detection of unknown and uncontrolled diabetes mellitus (DM). There is a screening tool at our hospital: in case of high inpatient plasma glucose level, an A1c value is added if no available from the last 3 months.
Aims And Objectives: Our objective was to analyse the population with A1c ≥ 9% detected through this system from 2021 to 2023.
Objective: The PREDG trial was designed to study the influence of an educative program on gestational weight gain in women with pregestational obesity.
Methods: Randomized controlled clinical trial (https://www.isrctn.
Introduction: Tyrosine kinase inhibitors have been a breakthrough in the treatment of advanced medullary thyroid cancer (MTC), and they can prolong progression-free survival (PFS).
Case Presentation: A patient with MTC and metastatic spread to the lymph nodes, lungs, bones, breast, and cerebellum started treatment with vandetanib. During treatment, she developed secondary adrenal insufficiency and hypogonadotropic hypogonadism.